ASUS Launches AI-Powered Clinical Ecosystem to Bring Autonomous Agents to the Hospital Bedside
A new suite of portable medical devices connected by an AI agent platform aims to turn continuous patient data into instant clinical decisions, shifting healthcare AI from the lab to the frontline.
By Factlen Editorial Team
- Clinical Innovators
- Focus on the hardware-software integration and real-time decision-making capabilities.
- Public Health Advocates
- Focus on closing the discovery-delivery gap and reaching underserved populations.
- Frontline Practitioners
- Focus on alleviating staff shortages and reducing administrative burden through portable tools.
What's not represented
- · Patient Privacy Advocates
- · Health Insurance Providers
Why this matters
By moving artificial intelligence out of the research lab and into portable, rugged medical devices, this technology allows doctors to make faster, more accurate diagnoses at the patient's bedside, directly combating the severe staffing shortages currently straining global health systems.
Key points
- ASUS launched a new vertically integrated AI-powered healthcare ecosystem at Computex 2026.
- The system connects the portable DuoScan ultrasound and VivoWatch 6 Plus via an AI Agent platform.
- The technology aims to create a closed-loop system that turns continuous patient data into instant clinical action.
- Public health experts emphasize that AI's greatest potential lies in delivering proven care to underserved patients.
- 68% of surveyed frontline healthcare workers expect AI agents to measurably improve their daily workflows.
At the Computex 2026 technology conference in Taipei, ASUS unveiled a vertically integrated AI healthcare ecosystem designed to move artificial intelligence out of the research lab and directly to the patient's bedside. The launch represents a significant hardware-driven push to make clinical AI tangible, portable, and immediately actionable for frontline medical workers.[1][4]
The new system connects two newly launched medical devices—the Handheld Ultrasound DuoScan and the VivoWatch 6 Plus—through a proprietary "AI Agent" platform. This architecture creates a closed-loop system that continuously captures biometric data, processes it at the edge, and triggers automated clinical workflows in real time without requiring constant human prompting.[2][5]
The launch arrives at a critical inflection point for medical technology. While the first wave of generative AI focused heavily on back-office documentation and long-term drug discovery, healthcare systems worldwide are currently buckling under severe staff shortages, increasing patient loads, and administrative bloat. Hospitals are increasingly desperate for tools that actively assist in patient care rather than simply generating more data to review.[2][6]
According to a recent survey of frontline medical staff conducted alongside the launch, 68 percent of respondents now expect AI agents to deliver a measurable, immediate impact on their daily clinical workflows. The industry demand has decisively shifted from passive insights to active, autonomous assistance that can scale a physician's reach.[1][3]

At the hardware level, the DuoScan ultrasound represents a major push toward untethered diagnostics. The fully wireless, IP68-rated device features a 192-element high-definition imaging array and a dual-probe design, available in either linear-plus-convex or linear-plus-phased array configurations to cover everything from abdominal to cardiac imaging.[2][4]
At the hardware level, the DuoScan ultrasound represents a major push toward untethered diagnostics.
Because it offers up to three hours of continuous battery life and is completely sealed against dust and water, the DuoScan allows physicians to perform real-time imaging in emergency rooms, intensive care units, or even during remote home visits. This completely bypasses the need for heavy, fixed hospital infrastructure and brings the diagnostic tool directly to the patient.[3][5]
Complementing the acute-care imaging is the VivoWatch 6 Plus, a titanium-cased wearable with a sapphire-crystal AMOLED display designed for longitudinal patient monitoring. The device is built to withstand the rigors of continuous clinical deployment while maintaining a premium aesthetic that encourages patient compliance.[2][3]

Beyond standard blood pressure and electrocardiogram (ECG) tracking, the new smartwatch introduces advanced metrics like sleep breathing movement tracking and detailed gait analysis. These continuous data streams allow the AI platform to detect early warning signs of chronic disease, track recovery progress, and provide personalized wellness coaching directly to the user.[4][5]
The true breakthrough, however, lies in the software layer connecting these devices. The ASUS AI Agent acts as the connective tissue, analyzing the continuous stream of structured data from the wearables and imaging tools to feed validated results back to clinicians. By automating the analysis, the system allows doctors to focus on the final intervention rather than the raw data gathering.[4][5]
This shift aligns closely with the evolving philosophy of leading public health experts. At the recent "New Wave of AI in Healthcare 2026" conference, former New York City Health Commissioner Dr. Dave Chokshi argued that the industry's obsession with discovering the "next miracle cure" often overshadows a more pressing failure: the inability to deliver proven care to patients who already need it.[6]

Chokshi noted that tools capable of reclaiming time for clinicians, reducing administrative waste, and helping patients navigate complex care systems will likely do more for aggregate health outcomes than tools that merely accelerate documentation. He stressed that the true promise of AI is closing the "discovery-delivery gap."[6]
By establishing a "medical sandbox" that unifies sensing, platform, and computing layers, ASUS is attempting to build the exact infrastructure required to close that gap. If successful, the ecosystem could transform fragmented hospital processes into a cohesive, intelligent network that reduces physician burnout and restores the human element of care.[3][5][6]
How we got here
Late 2022 - 2024
Generative AI models rapidly enter the healthcare space, primarily focused on administrative documentation and drug discovery.
May 2026
At the 'New Wave of AI in Healthcare' conference, public health leaders urge a shift in focus toward using AI to close the 'discovery-delivery gap'.
June 2, 2026
ASUS unveils its vertically integrated AI healthcare ecosystem at Computex in Taipei, featuring the DuoScan and VivoWatch 6 Plus.
Viewpoints in depth
Clinical Innovators
Focus on the hardware-software integration and real-time decision-making capabilities.
Technology developers and hardware manufacturers view the integration of AI agents as the necessary evolution of medical devices. Rather than simply displaying raw data for a human to interpret later, they argue that devices must now process that data at the edge, triggering immediate alerts and automated workflows. This closed-loop approach is seen as the key to scaling precision medicine without proportionally increasing the cognitive load on physicians.
Public Health Advocates
Focus on closing the discovery-delivery gap and reaching underserved populations.
Public health experts caution against measuring AI's success solely by its ability to invent new drugs or predict rare diseases. They argue that the technology's greatest promise lies in logistics and delivery—ensuring that proven, existing treatments actually reach the patients who routinely fall through the cracks. From this perspective, AI ecosystems that reduce administrative bloat and extend care into patients' homes are the true breakthroughs.
Frontline Practitioners
Focus on alleviating staff shortages and reducing administrative burden through portable tools.
For nurses, emergency responders, and attending physicians, the appeal of AI agents is strictly practical. Facing unprecedented staffing shortages and burnout, frontline workers prioritize tools that are portable, durable, and capable of operating independently of fixed hospital infrastructure. They value AI that can passively monitor patients and handle documentation, allowing them to spend more time on direct patient care.
What we don't know
- How seamlessly the ASUS AI Agent platform will integrate with existing, legacy Electronic Health Record (EHR) systems in major hospitals.
- The exact pricing and global rollout timeline for the DuoScan and VivoWatch 6 Plus devices.
- How regulatory bodies like the FDA will classify and approve the autonomous decision-making capabilities of the AI Agent software.
Key terms
- AI Agent
- An autonomous software system that can continuously monitor data, make decisions, and execute workflows without requiring constant human prompting.
- Closed-Loop System
- A technological architecture where data collection, analysis, and the resulting actions feed into each other continuously and automatically.
- Gait Analysis
- The assessment of a person's walking pattern, which can provide early warning signs for various neurological or musculoskeletal conditions.
- IP68 Rating
- A certification indicating that a device is fully protected against dust and can withstand continuous immersion in water, which is essential for rigorous sterilization in medical environments.
Frequently asked
What is the ASUS Handheld Ultrasound DuoScan?
It is a portable, fully wireless ultrasound device featuring a 192-element high-definition imaging array. It is designed to be used in emergency rooms, ICUs, and home care settings without needing to be plugged into a wall.
What new features does the VivoWatch 6 Plus track?
In addition to standard blood pressure and ECG monitoring, the new smartwatch tracks sleep breathing movement and performs continuous gait analysis to detect early signs of chronic disease.
What is an AI agent in healthcare?
Unlike passive AI that simply analyzes data when prompted by a human, an AI agent is an autonomous software system that continuously monitors patient data and can trigger automated clinical workflows or alerts in real time.
Why is the 'discovery-delivery gap' important?
Public health experts note that while medicine has discovered cures for many diseases, health systems often fail to deliver those treatments to the patients who need them. AI ecosystems are increasingly being viewed as a tool to solve these logistical failures.
Sources
[1]ASUSClinical Innovators
ASUS Advances AI-Driven Healthcare at Computex 2026
Read on ASUS →[2]mHealthSpotFrontline Practitioners
ASUS has launched an AI-powered healthcare ecosystem
Read on mHealthSpot →[3]Healthcare DigitalFrontline Practitioners
ASUS's AI-powered technology aims to empower healthcare professionals
Read on Healthcare Digital →[4]Health AI InsidersClinical Innovators
ASUS Unveils Integrated AI Healthcare System at Computex
Read on Health AI Insiders →[5]NE HeraldFrontline Practitioners
ASUS Unveils AI-Powered Healthcare Ecosystem
Read on NE Herald →[6]New York Academy of SciencesPublic Health Advocates
Healthcare's Real AI Breakthrough May Be Getting Proven Care to More Patients
Read on New York Academy of Sciences →
More in ai
See all 7 stories →Local AI
The Rise of Local AI: How to Run Powerful LLMs on Your Own Laptop
0 sources
Open Source AI
Open-Source AI Reaches Frontier Parity as MiniMax M3 and Local Agents Break the Cloud Monopoly
0 sources
Materials Science
How AI is Compressing Decades of Battery Research into Days
0 sources
AI in Medicine
UK Launches World's First AI Regulatory Sandbox to Transform Medicines Safety and Drug Development
0 sources
Every angle. Every day.
Get ai stories with full source coverage and perspective breakdowns delivered to your inbox.











